|
⚲
|
| Keyboard |
| Tester Jason E
✚
|
|
|---|---|
| CIK # | 0001827272 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001827272] | |
| 4 | [0001827272] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tester Jason E | |
| Tarsus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tarsus Pharmaceuticals Inc TARS
Stock Option (right to buy) · derivative
|
2021-06-15 | Grant | 10,000 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Stock Option (right to buy) · derivative
|
2021-06-15 | Grant | 10,000 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Buy | 3,125 | $16.00 | 50,000 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 1,434,790 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 245,966 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Buy | 168,750 | $16.00 | 2,700,000 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 71,427 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 21,575 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series B Preferred Stock · derivative
|
2020-10-20 | Conversion | 245,966 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series C Preferred Stock · derivative
|
2020-10-20 | Conversion | 71,427 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,434,790 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 21,575 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series B Preferred Stock · derivative
|
2020-10-20 | Conversion | 3,698 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 3,698 |